CD8A and neoplasm: In a different approach, Woo et al. showed that host APCs in the tumor microenvironment can incorporate tumor-derived DNA, which is proposed to be involved in the activation of the STING pathway, leading to IFN-β production and priming of CD8+ T cells against tumor antigens in vivo (119).